SynthesisBMC public health2022

Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review.

Wendy A Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.